# Biomarkers in biliary atresia – an elusive promise of predicting outcome

## TL;DR

This paper discusses the ongoing challenge of using biomarkers to predict outcomes in biliary atresia, focusing on amyloid-related genes and the need for improved methods.

## Contribution

The paper suggests shifting focus to post-Kasai portoenterostomy biomarkers and using composite scores for better outcome prediction.

## Key findings

- Current biomarker research in biliary atresia has not yet achieved its goal of predicting outcomes.
- Amyloid precursor protein in plasma samples is being explored for outcome prediction in biliary atresia.
- Serial evaluations and composite scores may improve prognostication in biliary atresia.

## Abstract

Research on biomarkers in BA promises to predict and change outcomes in BA. This goal is still unrealized at the moment. The study by Kamp et al attempts to understand the drivers of fibrosis and elucidate the role of amyloid-related genes in the pathophysiology of BA. Based on this, they attempt to predict outcomes in BA using biomarkers by analysing plasma samples for amyloid precursor protein. There is a need to evaluate if shifting the focus from pre-KPE biomarkers to post-KPE biomarkers, serial evaluations and the use of composite scores could help in better prognostication.